{"id":27457,"date":"2023-08-30T22:49:28","date_gmt":"2023-08-30T20:49:28","guid":{"rendered":"https:\/\/patientenstimme-sma.de\/?p=27457"},"modified":"2026-03-16T21:04:50","modified_gmt":"2026-03-16T20:04:50","slug":"evrysdi-nun-auch-zur-behandlung-unter-2-monaten-zugelassen","status":"publish","type":"post","link":"https:\/\/smartunity.space\/stories\/thema\/evrysdi-nun-auch-zur-behandlung-unter-2-monaten-zugelassen\/","title":{"rendered":"Evrysdi\u00ae nun auch zur Behandlung unter 2 Monaten zugelassen"},"content":{"rendered":"\n<p>Wie in einem aktuellen Mediarelease von Roche zu lesen, hat die European Medicines Agency die Erweiterung der Behandlung von Neugeborenen nun auch ab einem alter unter 2 Monaten zugelassen.<\/p>\n\n\n\n<p>Somit ist Evrysdi\u00ae nun auch direkt nach der Geburt zur Behandlung von Neugeborenen mit molekulargenetisch nachgewiesener 5q-assoziierter spinaler Muskelatrophie verf\u00fcgbar.<\/p>\n\n\n\n<p>Quelle: <a href=\"https:\/\/www.roche.com\/media\/releases\/med-cor-2023-08-29\" data-type=\"link\" data-id=\"https:\/\/www.roche.com\/media\/releases\/med-cor-2023-08-29\">Roche Medialrelease<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Wie in einem aktuellen Mediarelease von Roche zu lesen, hat die European Medicines Agency die Erweiterung der Behandlung von Neugeborenen nun auch ab einem alter unter 2 Monaten zugelassen. Somit ist Evrysdi\u00ae nun auch direkt nach der Geburt zur Behandlung von Neugeborenen mit molekulargenetisch nachgewiesener 5q-assoziierter spinaler Muskelatrophie verf\u00fcgbar. Quelle: Roche Medialrelease<\/p>\n","protected":false},"author":1,"featured_media":18044,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"only-view","format":"standard","meta":{"activitypub_content_warning":"","activitypub_content_visibility":"","activitypub_max_image_attachments":0,"activitypub_interaction_policy_quote":"anyone","activitypub_status":"","footnotes":""},"categories":[1],"tags":[58],"class_list":["post-27457","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-thema","tag-smanews"],"_links":{"self":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/27457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/comments?post=27457"}],"version-history":[{"count":1,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/27457\/revisions"}],"predecessor-version":[{"id":39767,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/27457\/revisions\/39767"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/media\/18044"}],"wp:attachment":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/media?parent=27457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/categories?post=27457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/tags?post=27457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}